Arcadia Biosciences Inc (NASDAQ:RKDA) CEO Matthew Plavan tells Proactive the California-based group's 2Q revenue growth was fueled by GLA sales and GoodWheat royalties. Plavan says the company also cinched a trio of recent GoodWheat agreements: a collaboration with Corner Foods to bring its products to China and Israel, a partnership with Three Farm Daughters to develop and market GoodWheat products and a deal with GoodMills to sell the products in Europe.
viewArcadia Biosciences Inc
Arcadia Biosciences reports strong 2Q revenue despite coronavirus impact
Quick facts: Arcadia Biosciences Inc
Price: 3.36 USD
NASDAQ:RKDA
Market: NASDAQ
Market Cap: $71.66 m
Follow
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Arcadia Biosciences Inc named herein, including the promotion by the Company of Arcadia Biosciences Inc in any Content on the Site, the Company...
FOR OUR FULL DISCLAIMER CLICK HEREDeep dive
Arcadia Biosciences is looking to grow a healthier world
Most read
Health
Cannabis company MGC Pharmaceuticals soars on food supplement product deal
6 days, 6 hours ago
Health
MGC Pharmaceuticals signs supply and distribution agreement with Swiss...
6 days, 15 hours ago
Mining
Lake Resources demonstrates clean technology path for high purity lithium as...
5 days, 17 hours ago
